Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204412671> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3204412671 endingPage "5116" @default.
- W3204412671 startingPage "5107" @default.
- W3204412671 abstract "Background/Aim: We evaluated local control and toxicity in patients receiving radiotherapy associated with immune check point inhibitors and analyzed which oligometastatic disease setting benefits the most from local ablation in terms of advantage in overall survival. Patients and Methods: We retrospectively identified 60 oligoprogressive patients treated with a PD-1 inhibitor in association with radiotherapy on the site of progression (119 lesions). Results: After a median follow-up of 11.7 months (range=1-39 months), we observed complete response (CR) in 45/119, partial response (RP) in 42/119, and stable disease (SD) in 30/119 patients. Nine radionecrotic events occurred. Two patients experienced grade 3 toxicities and 32 patients reported grade 2 toxicities. The number of radiologically evident metastatic organs in patients who received concomitant PD-1 inhibitors and radiotherapy showed a significant increase in survival (respectively, 73% after 12 months and 47% after 24 months) in patients with 0-3 metastatic organs compared to those with more than 3 organ sites involved (p<0.0001). Conclusion: Radiotherapy associated with PD-1 inhibitors is overall safe and efficacious. Patients eligible for intensification of local treatments should have less or equal to 3 metastatic organ sites." @default.
- W3204412671 created "2021-10-11" @default.
- W3204412671 creator A5003630947 @default.
- W3204412671 creator A5004287048 @default.
- W3204412671 creator A5009174144 @default.
- W3204412671 creator A5010590195 @default.
- W3204412671 creator A5040070729 @default.
- W3204412671 creator A5043003981 @default.
- W3204412671 creator A5048429301 @default.
- W3204412671 creator A5069369968 @default.
- W3204412671 creator A5078946355 @default.
- W3204412671 creator A5087162477 @default.
- W3204412671 creator A5088836572 @default.
- W3204412671 date "2021-09-30" @default.
- W3204412671 modified "2023-09-23" @default.
- W3204412671 title "Stereotactic and Hypofractionated Radiotherapy Associated With Immune Checkpoint Inhibitor Drugs: Analysis of Local Control, Toxicity, and Outcome in a Single Research Centre Case Study" @default.
- W3204412671 doi "https://doi.org/10.21873/anticanres.15327" @default.
- W3204412671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34593461" @default.
- W3204412671 hasPublicationYear "2021" @default.
- W3204412671 type Work @default.
- W3204412671 sameAs 3204412671 @default.
- W3204412671 citedByCount "1" @default.
- W3204412671 countsByYear W32044126712023 @default.
- W3204412671 crossrefType "journal-article" @default.
- W3204412671 hasAuthorship W3204412671A5003630947 @default.
- W3204412671 hasAuthorship W3204412671A5004287048 @default.
- W3204412671 hasAuthorship W3204412671A5009174144 @default.
- W3204412671 hasAuthorship W3204412671A5010590195 @default.
- W3204412671 hasAuthorship W3204412671A5040070729 @default.
- W3204412671 hasAuthorship W3204412671A5043003981 @default.
- W3204412671 hasAuthorship W3204412671A5048429301 @default.
- W3204412671 hasAuthorship W3204412671A5069369968 @default.
- W3204412671 hasAuthorship W3204412671A5078946355 @default.
- W3204412671 hasAuthorship W3204412671A5087162477 @default.
- W3204412671 hasAuthorship W3204412671A5088836572 @default.
- W3204412671 hasConcept C126322002 @default.
- W3204412671 hasConcept C141071460 @default.
- W3204412671 hasConcept C143998085 @default.
- W3204412671 hasConcept C203092338 @default.
- W3204412671 hasConcept C2779384505 @default.
- W3204412671 hasConcept C29730261 @default.
- W3204412671 hasConcept C509974204 @default.
- W3204412671 hasConcept C535046627 @default.
- W3204412671 hasConcept C71924100 @default.
- W3204412671 hasConcept C90924648 @default.
- W3204412671 hasConceptScore W3204412671C126322002 @default.
- W3204412671 hasConceptScore W3204412671C141071460 @default.
- W3204412671 hasConceptScore W3204412671C143998085 @default.
- W3204412671 hasConceptScore W3204412671C203092338 @default.
- W3204412671 hasConceptScore W3204412671C2779384505 @default.
- W3204412671 hasConceptScore W3204412671C29730261 @default.
- W3204412671 hasConceptScore W3204412671C509974204 @default.
- W3204412671 hasConceptScore W3204412671C535046627 @default.
- W3204412671 hasConceptScore W3204412671C71924100 @default.
- W3204412671 hasConceptScore W3204412671C90924648 @default.
- W3204412671 hasIssue "10" @default.
- W3204412671 hasLocation W32044126711 @default.
- W3204412671 hasOpenAccess W3204412671 @default.
- W3204412671 hasPrimaryLocation W32044126711 @default.
- W3204412671 hasRelatedWork W2082912800 @default.
- W3204412671 hasRelatedWork W2106653639 @default.
- W3204412671 hasRelatedWork W2410406217 @default.
- W3204412671 hasRelatedWork W3208389371 @default.
- W3204412671 hasRelatedWork W4221070417 @default.
- W3204412671 hasRelatedWork W4248512896 @default.
- W3204412671 hasRelatedWork W4252107748 @default.
- W3204412671 hasRelatedWork W4294682775 @default.
- W3204412671 hasRelatedWork W4306253774 @default.
- W3204412671 hasRelatedWork W4362458206 @default.
- W3204412671 hasVolume "41" @default.
- W3204412671 isParatext "false" @default.
- W3204412671 isRetracted "false" @default.
- W3204412671 magId "3204412671" @default.
- W3204412671 workType "article" @default.